Clinical Trial Update: A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating risperidone and topiramate given alone and in combination in patients with bipolar disorder or schizoaffective disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorder | Phase 1 | Status: COMPLETED